Literature DB >> 4204928

[Results of daily-oral therapy with ethambutol and isoniazid in tuberculosis (author's transl)].

H K Schwabe, A Heymer, A Wahlen, M Stollenwerk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4204928     DOI: 10.1007/bf02148560

Source DB:  PubMed          Journal:  Pneumonologie        ISSN: 0033-4073


× No keyword cloud information.
  10 in total

1.  Results of out-patient anti-tuberculous chemotherapy after discharge from the hospital.

Authors:  H I HUMPHREY; P TCHEN
Journal:  Dis Chest       Date:  1960-05

2.  Safety evaluation of ethambutol.

Authors:  H F Diermeier; J A Kaiser; N Yuda
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

3.  Clinical evaluation of ethambutol in pulmonary tuberculosis.

Authors:  I Donomae; K Yamamoto
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

4.  [Evolutionary aspects of tuberculosis during a subsiding epidemic].

Authors:  P Steinbrück
Journal:  Pneumonologie       Date:  1970

5.  [Clinical experiences with the new antitubercular agent Myambutol].

Authors:  S Kilic
Journal:  Med Klin       Date:  1968-12-20

6.  The ocular toxicity of ethambutol and its relation to dose.

Authors:  J E Leibold
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

7.  Ethambutol: a substitute for para-aminosalicylic acid in regimens for pulmonary tuberculosis.

Authors:  S H Ferebee; B E Doster; F J Murray
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

8.  Comparison of ethambutol-INH versus INH-PAS in original treatment of pulmonary tuberculosis.

Authors:  I D Bobrowitz
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

9.  Multiple retreatment drug regimens for pulmonary tuberculosis.

Authors:  R F Johnston; H W Harris; R A Knight; A Dufour; J B Waller
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

10.  Ethambutol in the retreatment and primary treatment of tuberculosis: a four-year clinical investigation.

Authors:  M M Pyle
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.